Opexa Therapeutics Company
Opexa Therapeutics develops patient-specific immunotherapies for the treatment of multiple sclerosis.
Technology:
Cell-based gene therapy
Industry:
Delisted, Small&Large Molecules
Headquarters:
Houston, Texas, United States
Founded Date:
1986-01-01
Employees Number:
11-50
Funding Status:
M&A
Total Funding:
5836000
Last Funding Date:
2013-02-19
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership